Steven E. Come

9.8k total citations · 1 hit paper
166 papers, 6.7k citations indexed

About

Steven E. Come is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Steven E. Come has authored 166 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Oncology, 63 papers in Cancer Research and 37 papers in Genetics. Recurrent topics in Steven E. Come's work include Breast Cancer Treatment Studies (57 papers), Cancer Treatment and Pharmacology (30 papers) and HER2/EGFR in Cancer Research (26 papers). Steven E. Come is often cited by papers focused on Breast Cancer Treatment Studies (57 papers), Cancer Treatment and Pharmacology (30 papers) and HER2/EGFR in Cancer Research (26 papers). Steven E. Come collaborates with scholars based in United States, Canada and United Kingdom. Steven E. Come's co-authors include Ann H. Partridge, Lidia Schapira, Shari Gelber, Eric P. Winer, Jay R. Harris, Barbara Silver, Abram Recht, Kathryn J. Ruddy, Rulla M. Tamimi and Rebecca Gelman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Steven E. Come

158 papers receiving 6.4k citations

Hit Papers

A clinical-pharmacological evaluation of hepatic arterial... 1978 2026 1994 2010 1978 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.
    1978 414 citations Steven E. Come et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven E. Come United States 44 3.9k 2.6k 1.5k 1.2k 1.2k 166 6.7k
Robert Leonard United Kingdom 41 3.9k 1.0× 1.9k 0.7× 1.1k 0.7× 626 0.5× 1.1k 0.9× 201 6.6k
Stefan Aebi Switzerland 38 4.2k 1.1× 3.1k 1.2× 1.2k 0.8× 1.9k 1.5× 909 0.8× 141 7.8k
Byeong‐Woo Park South Korea 42 2.4k 0.6× 2.4k 0.9× 766 0.5× 1.5k 1.2× 629 0.5× 210 5.3k
Constance Cirrincione United States 38 6.8k 1.7× 4.7k 1.8× 1.6k 1.0× 1.6k 1.3× 810 0.7× 81 9.8k
S. Ashley United Kingdom 47 3.1k 0.8× 2.0k 0.8× 2.1k 1.4× 1.1k 0.9× 1.2k 1.0× 127 7.1k
Gloria Broadwater United States 42 3.1k 0.8× 1.8k 0.7× 1.0k 0.7× 592 0.5× 652 0.6× 182 6.2k
Laura F. Hutchins United States 40 4.0k 1.0× 1.5k 0.6× 1.7k 1.1× 700 0.6× 662 0.6× 121 7.2k
Olivia Pagani Switzerland 42 3.4k 0.9× 1.8k 0.7× 1.5k 1.0× 435 0.4× 1.3k 1.1× 159 5.5k
Gabe S. Sonke Netherlands 42 4.2k 1.1× 2.3k 0.9× 1.7k 1.1× 925 0.8× 558 0.5× 314 8.2k
Michael Andersson Denmark 37 3.2k 0.8× 2.2k 0.9× 1.7k 1.1× 1.6k 1.3× 451 0.4× 123 7.6k

Countries citing papers authored by Steven E. Come

Since Specialization
Citations

This map shows the geographic impact of Steven E. Come's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Come with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Come more than expected).

Fields of papers citing papers by Steven E. Come

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven E. Come. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Come. The network helps show where Steven E. Come may publish in the future.

Co-authorship network of co-authors of Steven E. Come

This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Come. A scholar is included among the top collaborators of Steven E. Come based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Come. Steven E. Come is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Yue, Laura C. Collins, Yujing J. Heng, et al.. (2025). Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor–Positive Breast Cancer. Clinical Cancer Research. OF1–OF11. 1 indexed citations
2.
Sella, Tal, Shoshana M. Rosenberg, Gregory J. Kirkner, et al.. (2024). Breastfeeding experiences among young breast cancer survivors: A survey study. Cancer. 131(1). e35585–e35585. 3 indexed citations
3.
Sella, Tal, Yue Zheng, Shoshana M. Rosenberg, et al.. (2023). Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. npj Breast Cancer. 9(1). 31–31. 3 indexed citations
4.
Lipsyc-Sharf, Marla, Esha Jain, Laura C. Collins, et al.. (2023). Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. JCO Precision Oncology. 7(7). e2300076–e2300076. 3 indexed citations
5.
Sella, Tal, Shoshana M. Rosenberg, Shari Gelber, et al.. (2023). Abstract P5-08-06: Breastfeeding in Survivors of Early Breast Cancer. Cancer Research. 83(5_Supplement). P5–8. 2 indexed citations
6.
Collins, Laura C., Yue Zheng, Nabihah Tayob, et al.. (2023). Association of tumor-infiltrating lymphocytes (TILs) with clinicopathologic characteristics and prognosis in young women with HR+/HER2- breast cancer (BC).. Journal of Clinical Oncology. 41(16_suppl). 505–505. 1 indexed citations
7.
Sella, Tal, Shoshana M. Rosenberg, Gregory J. Kirkner, et al.. (2023). Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors. Cancer. 130(4). 517–529. 2 indexed citations
8.
Sella, Tal, Geoffrey Fell, Peter G. Miller, et al.. (2022). Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Advances. 6(24). 6151–6161. 8 indexed citations
9.
Sella, Tal, Yue Zheng, Shoshana M. Rosenberg, et al.. (2022). Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors. Cancer. 128(17). 3158–3169. 10 indexed citations
10.
Schapira, Lidia, Yue Zheng, Shari Gelber, et al.. (2021). Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 128(2). 335–343. 69 indexed citations
11.
Sella, Tal, Philip D. Poorvu, Kathryn J. Ruddy, et al.. (2021). Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 127(16). 2888–2894. 32 indexed citations
12.
Pak, Linda M., Shoshana M. Rosenberg, Kathryn J. Ruddy, et al.. (2020). Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Research and Treatment. 186(3). 815–821. 5 indexed citations
13.
Borstelmann, Nancy A., Shoshana M. Rosenberg, Shari Gelber, et al.. (2020). Partners of young breast cancer survivors: a cross-sectional evaluation of psychosocial concerns, coping, and mental health. Journal of Psychosocial Oncology. 38(6). 670–686. 16 indexed citations
14.
Poorvu, Philip D., Shari Gelber, Shoshana M. Rosenberg, et al.. (2019). Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. Journal of Clinical Oncology. 38(7). 725–733. 48 indexed citations
15.
Collins, Laura C., Shari Gelber, Jonathan D. Marotti, et al.. (2015). Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. The Oncologist. 20(7). 713–718. 15 indexed citations
16.
Partridge, Ann H., R. Bryan Rumble, Lisa A. Carey, et al.. (2014). Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 32(29). 3307–3329. 194 indexed citations
17.
Mayer, Erica L., Lyndsay N. Harris, Julie Gold, et al.. (2014). Long-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer. Clinical Breast Cancer. 15(1). 24–30. 11 indexed citations
18.
19.
20.
Recht, Abram, Stuart J. Schnitt, James L. Connolly, et al.. (1989). Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. International Journal of Radiation Oncology*Biology*Physics. 16(1). 3–9. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Leonard Breakdown of academic impact, for papers by Stefan Aebi Breakdown of academic impact, for papers by Byeong‐Woo Park Breakdown of academic impact, for papers by Constance Cirrincione Breakdown of academic impact, for papers by S. Ashley Breakdown of academic impact, for papers by Gloria Broadwater Breakdown of academic impact, for papers by Laura F. Hutchins Breakdown of academic impact, for papers by Olivia Pagani Breakdown of academic impact, for papers by Gabe S. Sonke Breakdown of academic impact, for papers by Michael Andersson
Rankless by CCL
2026